Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

There are details that will be outlined for K and P that will give a better idea for both better valuation and improved sense of timing for trials. For K details would include more info regarding the last cohort for the final 20 Patients as well as an update on the number of those 20 now having completed dosing. Then there is the UoB trial for AML which would include either confirmation of the start of the trial or the near term estimate for its start.

b details are what we should all be looking forward to. First would be more information on the QIDP and exactly which fast-track elements will be applied. We know there will be at least one early assessment, but can the next trial be modified to a phase 4? Any update on B-OM will confirm the speed at which the trial can be completed: 1 year, 5 years. The market is acting like it's the latter.

Then there is Prurisol. That is a 1 year trial, and confirmation of enrollment starts the clock.

Price catalysts abound: financial disclosings showing a significantly lower burn rate than anticipated, hints at a license, preliminary or other trial details, confirmation of more institutional ownership.....